Can You Reverse Heart Disease? What My Plaque Scans Showed | Dr Campbell Rogers

Coronary artery disease management is shifting from population-based risk scores toward direct, quantitative imaging of arterial plaque. Dr. Campbell Rogers, an interventional cardiologist and Chief Medical Officer at Heartflow, explains how AI-driven analysis of coronary CT angiography provides precise, patient-specific data on plaque volume and composition. Unlike traditional methods that rely on indirect biomarkers like cholesterol levels, this technology enables clinicians to visualize disease progression or regression directly. By identifying plaque before it restricts blood flow or causes symptoms, patients and physicians can make more informed, aggressive decisions regarding lifestyle modifications and lipid-lowering therapies. This diagnostic evolution, validated by prospective studies against intravascular ultrasound, offers a more accurate assessment of individual cardiovascular health, potentially reducing the reliance on invasive diagnostic procedures and improving long-term outcomes for those with early-stage atherosclerosis.